STOCK TITAN

Our Commitment to Caregivers

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Alkermes (ALKS) Recognizes National Caregivers Month 2023, Highlights Support for Caregiving Employees
Positive
  • None.
Negative
  • None.

NORTHAMPTON, MA / ACCESSWIRE / November 14, 2023 / This month, Alkermes acknowledges the important role of family members who are caregivers for their loved ones. We applaud your selflessness, dedication and unconditional love. Your efforts inspire us to continue developing innovative medicines that have the potential to make a meaningful difference. Hear from Steve Schiavo, our Senior Vice President of Human Resources, as he reflects on how we work to support caregiving employees: https://www.alkermes.com/news-and-events/national-caregivers-month-2023

View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com.

Contact Info:
Spokesperson: Alkermes
Website: https://www.3blmedia.com/profiles/alkermes
Email: info@3blmedia.com

SOURCE: Alkermes



View source version on accesswire.com:
https://www.accesswire.com/803368/our-commitment-to-caregivers

FAQ

What is Alkermes acknowledging this month?

Alkermes acknowledges the important role of family members who are caregivers for their loved ones.

Who reflected on the support for caregiving employees at Alkermes?

Steve Schiavo, the Senior Vice President of Human Resources at Alkermes, reflected on how they work to support caregiving employees.

Where can we hear from Steve Schiavo?

You can hear from Steve Schiavo on the Alkermes website: https://www.alkermes.com/news-and-events/national-caregivers-month-2023

Where can we find additional ESG storytelling from Alkermes?

Additional ESG storytelling from Alkermes can be found on 3blmedia.com.

What is the contact information for Alkermes?

Spokesperson: Alkermes, Website: https://www.3blmedia.com/profiles/alkermes, Email: info@3blmedia.com

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.06B
158.79M
1.25%
108.01%
8.58%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
DUBLIN 4

About ALKS

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.